Back to search
Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) trials you may qualify forThe purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with moderately to severely active ulcerative col…
The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of u…
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and…
The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy ea…
The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of t…
The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) pr…
Inflammatory bowel disease (IBD), primarily ulcerative colitis (UC) and Crohn's disease (CD), is a chronic disease entity affecting individuals of all ages, and…
The purpose of this study is to collect long-term safety data of subcutaneous (SC) ustekinumab
The purpose of this study is to evaluate the long-term safety and clinical status of pediatric patients with Inflammatory Bowel Disease (IBD). Particular attent…